Miach Orthopaedics
-
Recon
Miach Orthopaedics Announces BEAR® Implant Activities at OSET 2024
Scientific Presentations Highlight Patient Selection, Surgical Technique and Experience, Including Live Case Interim Analysis of the Bridge Registry Study to…
Read More » -
Sports Medicine
Miach Orthopaedics Raises $20 Million in Series B Extension
The Major League Soccer Players Association (MLSPA), SV Health Investors and Aperture Venture Partners Join Existing Investors to Support Commercial…
Read More » -
Sports Medicine
Miach Orthopaedics Launches BEAR® Implant Registry Study
Bridge Registry to Track Outcomes Up to Two Years WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a privately held company dedicated to…
Read More » -
Recon
Miach Orthopaedics Announces BEAR® Implant Distribution Agreement with Veteran’s Health Medical Supply
March 7, 2023 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from…
Read More » -
Financial
Miach Orthopaedics Secures $40 Million Financing
– Funds to Expand U.S. Commercialization of BEAR® Implant for Treatment of ACL Tears – WESTBOROUGH, Mass.–January 25, 2023 (BUSINESS…
Read More » -
Recon
Miach Orthopaedics Appoints Arjun Ishwar Vice President of Sales & Marketing
October 11, 2022 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from…
Read More » -
Recon
Miach Orthopaedics Appoints Patrick McBrayer President & CEO
September 7, 2022 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament tears from reconstruction…
Read More » -
Recon
Miach Orthopaedics Announces U.S. Commercial Availability of BEAR® Implant to Treat ACL Tears
Implant Also Receives a 2021 Popular Science “Best of What’s New” Award in Health December 1, 2021 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach…
Read More » -
Recon
Miach Orthopaedics Initiates Post-Market Study for BEAR® Implant
September 13, 2021 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective…
Read More » -
Recon
Miach Orthopaedics Names Stephen Wohlert, PhD, Vice President of Manufacturing
WESTBOROUGH, Massachusetts – January 21, 2020 – Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants…
Read More » -
Recon
Miach Orthopaedics Names Michael J. McNulty Vice President of Sales and Marketing
October 15, 2019 WESTBOROUGH, Massachusetts – Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue…
Read More » -
Recon
MRI Study Shows Miach Orthopaedics BEAR Implant Restores Torn ACL Quality and Size Similar to Native ACLs
July 23, 2019 WESTBOROUGH, Mass. – Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for…
Read More » -
Recon
Miach Orthopaedics Expands Senior Executive Team
April 17, 2019 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective…
Read More » -
Recon
Miach Orthopaedics Reports Encouraging Two-Year Results In Bridge-Enhanced® ACL Repair Feasibility Study
LAS VEGAS – March 12, 2019 – MIACH Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants…
Read More » -
Recon
Miach Orthopaedics Appoints Martha Shadan President and CEO
WESTBOROUGH, Massachusetts – Jan. 3, 2019 – Miach Orthopaedics, Inc. a privately held company dedicated to developing bio-engineered surgical implants for…
Read More »